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Deleted in breast cancer 1 (DBC1, CCAR2, KIAA1967) is a large, predominantly nuclear, multidomain protein that modulates gene
expression by inhibiting several epigenetic modifiers, including the deacetylases SIRT1 and HDAC3, and the methyltransferase
SUV39H1. DBC1 shares many highly conserved protein domains with its paralog cell cycle and apoptosis regulator 1 (CCAR1,
CARP-1). In this study, we examined the full-length sequential and structural properties of DBC1 and CCAR1 from multiple species
and correlated these properties with evolution. Our data shows that the conserved domains shared between DBC1 and CCAR1 have
similar domain structures, as well as similar patterns of predicted disorder in less-conserved intrinsically disordered regions. Our
analysis indicates similarities between DBC1, CCAR1, and the nematode protein lateral signaling target 3 (LST-3), suggesting that
DBC1 and CCAR1 may have evolved from LST-3. Our data also suggests that DBC1 emerged later in evolution than CCAR1. DBC1
contains regions that show less conservation across species as compared to the same regions in CCAR1, suggesting a continuously
evolving scenario for DBC1. Overall, this study provides insight into the structure and evolution of DBC1 and CCAR1, which may
impact future studies on the biological functions of these proteins.

1. Introduction
DBC1 (deleted in breast cancer 1, KIAA1967, CCAR2) and
paralog CCAR1 (cell cycle and apoptosis regulator 1, CARP1)
are emerging as important regulators for a variety of physiological processes. DBC1 was originally identified by its localization to a region of chromosome 8p21 that is homozygously
deleted in breast cancer. However, DBC1 is not localized to
the epicenter of the deletion and is therefore not the strongest
candidate tumor suppressor gene in this region [1, 2]. DBC1
is now also called CCAR2 (cell cycle and apoptosis regulator
2) in order to distinguish it from an unrelated protein that
is also named DBC1 (deleted in bladder cancer 1) [3]. DBC1
exerts some of its biological effects through interactions with
protein modifying enzymes, including the deacetylases SIRT1
and HDAC3, and the methyltransferase SUV39H1 [4–7].
Through its many interactions, DBC1 regulates a variety of
cellular processes including aging, metabolism, apoptosis,
and stress response pathways [4, 7–11]. DBC1 studies are

currently expanding to uncover new interacting partners and
the possibility of roles in other biological processes.
CCAR1 is the paralog to DBC1 that was originally identified as a mediator of apoptosis in a process that involves
sequestration of 14-3-3 and altered expression of multiple
cell cycle regulatory genes [8, 9, 12]. CCAR1 can bind to
the mediator complex and enhance transcription of estrogen
receptor and glucocorticoid receptor target genes and can act
as a coactivator for p53-dependent transcription [13]. CCAR1
can also cooperatively bind to DBC1 and synergistically
enhance estrogen receptor function [14]. Thus, like DBC1,
CCAR1 is also involved in a variety of cellular processes and
functions together with DBC1 in some cases.
DBC1 and CCAR1 share many of the same functional
domains including an S1-Like domain and a nuclear localization signal (NLS) on the N-terminus, a Leucine zipper
(LZ) domain and a Nudix domain that are centrally located,
and an EF-Hand domain and coiled-coil segments on the
C-terminus [9, 14, 15]. Experimental evidence regarding
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the specific functions of the S1-Like, Nudix, and EF-Hand
domains for both DBC1 and CCAR1 have not yet been
determined. CCAR1 (1150aa) is a larger protein compared
to DBC1 (923aa) due to the presence of two extra domains,
including a centrally located SAP domain and an extra coiledcoil segment found immediately after the SAP domain.
The N-terminus of DBC1 (aa1–264) is the region where
most of the currently known protein-protein interactions
have been mapped. The S1-Like domain was originally
identified in the ribosomal protein S1. Proteins that contain homology to this domain typically have RNA binding
capabilities, suggesting evolution from an ancient nucleic
acid binding protein [16]. The NLS is an important site
for regulation via post-translational modifications, where
acetylation can disrupt DBC1 translocation into the nucleus
and ultimately inhibit nuclear interactions [17]. The LZ is a
structural motif that functions as a dimerization domain and
can bind to DNA to regulate gene expression in DBC1, but it is
likely non-functional in CCAR1 [18]. DBC1 interactions with
epigenetic modifiers, nuclear receptors, and mRNA splicing
components all take place within the N-terminal area [4–
7, 14, 17]. The DBC1/SIRT1 interaction has been highly studied
due to the important role that DBC1 plays in inhibiting
the epigenetic modifications that are regulated by SIRT1.
Conflicting data points to either the LZ of DBC1 (aa243–264)
[4, 14, 19, 20] or the N-terminal amino acids 1–240 as being
critical for this interaction with SIRT1 [17].
The central region of DBC1 and CCAR1 contains a Nudix
domain that is catalytically inactive due to the absence of
key amino acid residues within the catalytic site. However, it
has been suggested to play a role in sensing the products of
the SIRT1 deacetylase reaction [9]. The SAP domain, specific
to CCAR1, is also centrally located. This domain shares
homology with a DNA binding motif commonly found in a
diverse set of nuclear proteins that are typically involved in
chromosomal organization [21].
The C-terminus of both DBC1 and CCAR1 contains
an EF-Hand domain. EF-Hand domains bind to calcium
ions and regulate gene expression but, similar to the Nudix
domain, the EF-Hand of DBC1 and CCAR1 may not be
functional because it is unlikely to bind to calcium ions
[8]. Both proteins also contain a coiled-coil segment in the
C-terminus, with an extra coiled-coil segment present in
CCAR1. Coiled-coil regions are known to contain important
protein interaction motifs [22]. The coiled-coil region of
DBC1 has been shown to interact with only one protein thus
far, the circadian cycle nuclear receptor Rev-erb𝛼. Overexpression of DBC1 can enhance the stability and expression
of Rev-erb𝛼, ultimately affecting circadian oscillations and
metabolism [23].
Evaluating the detailed evolutionary path that DBC1 and
CCAR1 have taken, and the factors that have influenced the
evolutionary path, will expand our knowledge base of these
two proteins. The presence of highly conserved domains
shared between DBC1 and CCAR1 indicates that DBC1
and CCAR1 may have evolved from one common ancestor.
Corresponding to this, an evolutionary connection between
DBC1 and CCAR1 has been reported in the large ortholog
database OrthoDB [24]. Interestingly, DBC1 and CCAR1 are
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predicted to be intrinsically disordered as demonstrated in
the D2P2 database of predicted disordered proteins [25].
As shown by previous studies on other proteins [26–36],
evolutionary analysis that takes protein intrinsic disorder into
account is particularly informative. Intrinsically disordered
regions within proteins can be critical for protein function,
as these regions are structurally flexible and are frequent
sites of protein interactions and various modifications [37–
40]. In many cases, intrinsically disordered regions are also
associated with higher substitution rates [32, 41, 42].
In this study, we have predicted the structural properties
of DBC1 and CCAR1, and our findings support the function
of both proteins in many protein-protein interactions due
to the high occurrence of disordered residues. Phylogenetic
analysis predicts that both DBC1 and CCAR1 evolved from
one common ancestor, the nematode protein LST-3. Collectively, this study provides insight into the future studies of
DBC1 and CCAR1 by evaluating both evolution and structure.

2. Materials and Methods
2.1. DBC1 Homologs and Paralogs. BLASTP [43, 44] was
used to align the human DBC1 (hDBC1) protein sequence
(UniProt ID: Q8N163) against the entire UniProt database
[45]. The obtained UniProt hits were filtered using a cutoff
alignment score set at 10% of the hDBC1-hDBC1 alignment score based on trial and error. The 129 sequences
that remained had a minimal sequence similarity of ∼30%
and a minimal sequence coverage of ∼50% as compared
to hDBC1, complying with previous studies [42]. After
removing redundant sequences using BLASTClust and cutoff
of 90% sequence identity, 93 sequences from 65 species
were used for analysis (Table S1; Supplementary Material
available online at http://dx.doi.org/10.1155/2014/418458). The
65 species include mammals, birds, reptiles, amphibians,
fish, insects, and nematodes. The proteins found include
DBC1, CCAR1, LST-3, and other undefined generic names. In
addition, the complete proteomes of human, zebrafish, and
C. elegans were downloaded from UniProt for comparative
studies.
2.2. Disorder Prediction. PONDR-FIT [46] and PONDRVLXT [47] were employed to run disorder prediction analysis. The disorder scores from both PONDR-FIT and PONDRVLXT were used to measure the flexibility of the amino acids
in all of the proteins examined. PONDR-FIT is one of the
most accurate disorder predictors as it adopts the metapredictor strategy. Metapredictors are prevailing in the field of disorder prediction due to improved accuracy [46, 48]. Many stateof-the-art disorder predictors are metapredictors [48–53].
PONDR-FIT uses an artificial neural network to optimize the
prediction results from six component predictors: PONDRVLXT [47], PONDR-VSL2 [54, 55], PONDR-VL3 [56, 57],
FoldIndex [58], IUPred [59], and TopIDP [60]. PONDRFIT improves the prediction accuracy significantly in various
testing datasets compared to its component predictors [46].
PONDR-VLXT is the first generation of disorder prediction
software that is specifically designed to detect local flexibility
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of amino acid sequences. Although PONDR-VLXT is not the
most accurate tool, it is still powerful due to its sensitivity to
amino acid composition [46, 61]. PONDR-VLXT has been
successfully applied in detecting linear interaction motifs
(MoRFs) [62–64], which have proven to be extremely abundant in protein-protein interactions [65–68]. The values of
predicted disorder scores were applied to measure the structural flexibility of proteins and the combination of disorder
scores from PONDR-VLXT, PONDR-FIT, and other predictors, has been applied in many studies in order to explore a
broad range of biological questions. Examples of these studies
include methionine oxidation [69], phosphorylation [70],
p53 evolution [42], binding motifs [71], iPS transcription
factors [72], PTEN interactions [70], the spliceosome [73],
the structural flexibility of viral proteins [72], and evolution
across species [74, 75]. In this paper, we have also used
predicted disorder scores to measure the structural flexibility
of whole protein sequences along with local regions.
2.3. CH-CDF Analysis. The previously mentioned predictors
were used to predict intrinsic disorder at a residue level.
Intrinsic disorder can also be measured at the entire sequence
level using a Charge-Hydropathy and Cumulative Distribution Function (CH-CDF) plot [51, 76]. A CH-CDF plot is
composed using parameters from both a Charge-Hydropathy
(CH) plot [77] and a Cumulative Distribution Function
(CDF) plot [78]. In each of these two plots, structured
proteins and disordered proteins stay in different regions and
can be separated by a linear boundary line. The distance of
a protein from the boundary line in each of them (dCH in
CH plot and dCDF in CDF plot) describes the tendency of
the protein being structured or disordered. The sign of the
distance (positive or negative) shows whether the entire protein is structured or disordered. The performances of these
two individual plots are often complementary. Therefore,
their combination improves the prediction accuracy at the
sequential level to 90% [51, 76]. In the CH-CDF plot, the
directional distance dCH in the CH plot is set as the 𝑦-axis,
and the directional distance dCDF in the CDF plot is used
as the 𝑥-axis. As dCH and dCDF both have positive and
negative values, the entire CH-CDF plot can be split into four
quadrants using dCH = 0 and dCDF = 0: (1) Q1, dCH ≥ 0 &
dCDF ≥ 0; (2) Q2, dCH < 0 & dCDF ≥ 0; (3) Q3, dCH < 0 &
dCDF < 0; and (4) Q4, dCH ≥ 0 & dCDF < 0. By definition,
proteins in Q2 are predicted to be structured. Proteins in Q3
and Q4 are disordered. Proteins in Q1 have excessive charged
residues but can be structured.
2.4. Three-Dimensional Structure Prediction. The 3D structure of the structured domains for both human DBC1 and
CCAR1 were built using HHpred [79], RaptorX [80], and ITASSER [81]. Each structured domain has three predicted
structures. The structure with the highest QMean score [82]
was selected as the final predicted structure.
2.5. Phylogenetic Analysis. Mega5 [83] was used to run multiple sequence alignments and to analyze the phylogeny of the
sequences. CLUSTALW was chosen to perform the multiple
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sequence alignment (default PAM matrix, Gap opening
score 10, and Gap extension score 0.1). Nearest-neighboring
algorithm was selected to analyze the phylogenetic relations among the sequences. The final phylogenetic tree was
obtained by bootstrapping 2000 times.
2.6. Genome Neighborhood Analysis. We calculated the Conservation of Genomic Neighborhood (CGN) score [84, 85]
of both DBC1 and CCAR1 for selected species, including
mammals, birds, insects, reptiles, amphibians, and fish. When
calculating the CGN score, all of the genes within a window
of two million bases from the center of DBC1 or CCAR1 of
that species were extracted from GeneBank. The number of
total genes in the window of the human genome was defined
as 𝑀HS , the number of common genes between human and
another species 𝑋 was counted as 𝐶𝑋 , and then the CGN
score of species 𝑋 was calculated as CGN𝑋 = 𝐶𝑋 /𝑀HS . The
human and mouse gene lists were also used to build a synteny
plot [86–88].
2.7. Mutation Rate Analysis. The substitution rate between
each group of domains between each species set is calculated
as follows. (1) Two groups of sequences were aligned using
CLUSTALW. (2) The domain structure of hCCAR1 was used
to label the location of similar regions in all of the other
sequences. (3) The amino acid of each sequence, on each site
within a specific region, in the second group was compared
with the amino acid sequence in the first group. If no match
was found, a substitution was recorded for this site. (4) This
process was repeated for each group with step (3) for all of
the sequences in the second group. The final substitution
frequency is 𝑆𝑖 for the 𝑖th site. (5) The sum was calculated
for all of the substitutions for the sites in the entire region
to get the total substitution ∑ 𝑆𝑖 (𝑖 = 1, . . . , 𝐿), where 𝐿 is the
number of sites in this region. (6) For example, if there were
𝑀 sequences in the first group and 𝑁 sequences in the second
group, the final substitution rate would be ∑ 𝑆𝑖 /(𝑀 ∗ 𝑁 ∗ 𝐿).

3. Results
3.1. DBC1 and CCAR1 Are Intrinsically Disordered Proteins
with a Similar Domain Structure and a Similar Pattern of Predicted Intrinsic Disorder. Human DBC1 (hDBC1) and human
CCAR1 (hCCAR1) have ∼30% sequence similarity to each
other (Figure S1) and share multiple highly conserved domains. Table 1 shows the sequential locations of the functional domains for both proteins and indicates the known or
predicted functions of the domains. The sequence alignment
of each domain is provided in Figures S2 and S3. The size
difference between DBC1 and CCAR1 is the result of three
segments found in hCCAR1 that hDBC1 lacks, including an
elongated N-terminal disordered region, a SAP domain, and
an extra coiled-coil segment in its C-terminus (CC1).
In order to compare the similarities in conformational
properties between hDBC1 and hCCAR1, the degree of
predicted protein intrinsic disorder of these two proteins
was analyzed (Figure 1). While 41% of hDBC1 is composed
of disordered residues, 61% of residues are disordered in
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Table 1: The domain structure and function of human DBC1 and CCAR1. The domains for hDBC1 and hCCAR1 are depicted along with the
amino acid boundaries for each domain. The known or predicted function of each of the conserved domains is listed.

hDBC1

hCCAR1

S1-Like
55–112

S1-Like
147–204

202–219
NLS

LZ
243–264

322–357
NLS

LZ
381–407

340–461
Nudix
478–586
Nudix

794–918
CC2

EF-Hand
704–748
SAP
637–669

874–902
CC1

EF-Hand
924–968

1033–1120
CC2

Domain Function
S1-Likea,b
NLSa,c
LZa,b,c,d
Nudixb
SAPa,b,d
EF-Handa,b
CCa,c,d

Homology to an RNA-binding domain.
Nuclear localization signal. Acetylation of the NLS in DBC1 regulates nuclear localization.
Likely non-functional in CCAR1. Regulation of a diverse set of cellular pathways in DBC1.
Catalytically inactive hydrolase domain in DBC1 and CCAR1. Predicted to function as a sensor in DBC1 that
may bind to NAD metabolites and regulate SIRT1.
Homology to a putative DNA-binding motif predicted to be involved in chromosomal organization.
Inactive variant of a calcium dependent regulator of multiple cellular processes.
Predicted protein-protein interaction motif.

Domain Boundary References: a: [8], b: [9], c: [14], d: [15].

hCCAR1. As expected, a majority of the functional domains
listed in Table 1, including the S1-Like, LZ, Nudix, and EFHand, are located in the structured segments of both proteins.
The domains that are intrinsically disordered, or have a high
degree of structural flexibility as indicated by higher disorder
score, are the NLS and coiled-coil segments on hDBC1 and
hCCAR1, as well as the SAP domain that is specific to
hCCAR1. The predicted 3D structures of these functional
domains indicate that many of these domains are structured
and have limited flexibility.
Analysis of the disorder curves on the C-terminal
residues (∼400aa) of hDBC1 and hCCAR1 indicates a high
degree of similarity on the curve of predicted protein intrinsic
disorder in this region, thereby suggesting a similar conformational fluctuation and further functional role (Figure 1,
shaded region). Corresponding to this finding, a sequence
alignment between these two regions shows 30% sequence
identity, indicating evolutionary conservation (Figure S3).
The high degree of similarity between the structure of the
conserved domains in hDBC1 and hCCAR1, along with the
similarity in the C-terminal region, leads to the presumption
that hDBC1 and hCCAR1 may share a common molecular
origin.
In addition to hDBC1 and hCCAR1, we determined the
sequence level of intrinsic disorder from other species using
a CH-CDF plot. We carried out CH-CDF analysis for all of the
proteins in our dataset and found that all DBC1 and CCAR1
proteins have large negative values (< −0.1) on CDF distance,
indicating that these proteins are mostly intrinsically disordered (Figure 2). In terms of CH distances, CCAR1 and DBC1
proteins have varying distributions. Most CCAR1 proteins
have a positive CH distance, while all DBC1 proteins have a
negative CH distance. Detailed analysis indicates that many
groups have localized distribution on this CH-CDF plot, such
as amphibian CCAR1 and bird CCAR1. Mammalian CCAR1
proteins have the broadest distribution on CH distance,

followed by CCAR1 proteins from aquatic animals. Compared to mammalian DBC1 proteins, mammalian CCAR1
proteins are more scattered in the CH-CDF plot, indicating
more structural variability. Therefore, based on the algorithms of CH and CDF distance, it can be concluded that most
CCAR1 proteins have extra charged residues, while almost all
DBC1 proteins are more structure-prone.
3.2. Human DBC1 Shares Common Ancestry with the Nematode CCAR1 Ortholog LST-3. To study the evolutionary relationship between DBC1 and CCAR1, phylogenetic analysis
was performed with the DBC1 homologs and paralogs listed
in Table S1, and the results are shown in Figure 3. Most mammals have evolved to incorporate both DBC1 and CCAR1 into
their genomes (Figure 3, purple shaded region). As a comparison, insects and nematodes have only incorporated CCAR1
into their genomes (Figure 3, light and dark blue shaded
regions). Interestingly, the first known evolutionary appearance of DBC1 is in zebrafish (Figure 3, pink shaded region).
This is a clear indication that DBC1 emerged later than
CCAR1. Another interesting observation is that the nematode
LST-3 proteins are more closely related to CCAR1 in lower
species, such as insects. These observations have revealed
an interesting evolutionary picture of DBC1/CCAR1/LST-3,
where DBC1 has evolved from CCAR1 and CCAR1 originated
from LST-3.
To compare homology between nematode LST-3 and
hDBC1/hCCAR1, a cross-validation between the nematode
proteome and the human proteome was performed. Specifically, the nematode Caenorhabditis elegans protein LST-3
was aligned against the complete human proteome and the
only two significant hits (𝐸 value < 1.0𝑒 − 20) were hDBC1
and hCCAR1. Conversely, both hDBC1 and hCCAR1 protein
sequences were aligned against the complete C. elegans
proteome, and the only significant hit was LST-3. This result
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Figure 1: Disorder analysis shows the domain structure and molecular flexibility of hDBC1 and hCCAR1. The curves present the disorder score predicted by PONDR-FIT (FIT, dark cyan) and PONDRVLXT (VLXT, dark pink). The 𝑥-axis of human DBC1 (hDBC1,
UniProtID: Q8N163) is shifted by 200 residues in order to align the
C-terminus to human CCAR1 (hCCAR1, UniProtID: Q8IX12). The
gray shadow behind PONDR-FIT represents the prediction of error.
Residues with a score higher than 0.5 are disordered, while residues
with a score lower than 0.5 are structured. The horizontal bars are the
conserved functional domains identified in both proteins (S1-Like:
aqua blue; NLS: medium blue; LZ: dark blue; Nudix: light purple;
SAP: medium purple; CC1: dark purple; EF-Hand: light pink; CC2:
dark pink). The predicted 3D structures are scaled roughly with their
lengths.

shows that the only possible ancestor of DBC1 and CCAR1 in
higher species is nematode LST-3.
To further explore the evolutionary path of LST-3,
CCAR1, and DBC1, we compared the full-length sequences of
C. elegans LST-3, zebrafish CCAR1 (zCCAR1), and zebrafish
DBC1 (zDBC1), as the first emergence of DBC1 is in zebrafish.
The resulting gapped-disorder curve of this comparison is
shown in Figure 4. A gapped disorder curve aligns proteins by
the shape of the curve based on the disorder score. Instead of
presenting the actual sequence similarity, the gapped disorder

C: mammal
C: amphibian
C: ocean
C: insect

C: bird
D: mammal
D: others
LST-3

Figure 2: CH-CDF analysis for all DBC1 and CCAR1 proteins. The
𝑥-axis and 𝑦-axis are the CDF and CH distances, respectively. The
CDF distance is calculated from PONDR-VSL2 prediction. All DBC1
proteins are split into two groups: mammal and others (starts with
“D” in the legend). All CCAR1 proteins are arranged into six groups,
including mammal, amphibian, aquatic animals, insect, and bird (as
denoted by “C” in the legend). Nematode LST-3 proteins are in one
group.

curve describes the overall similarity of the flexibility of the
protein segments, which indicates any evolutionary gaps that
may be present between proteins [72, 89, 90].
The structural similarities shared between zDBC1,
zCCAR1, and LST-3 include a structured segment present at
aa200 (Figure 4, shaded area 1), a similar disordered curvature spanning from aa200 to 400 (Figure 4, shaded area 2),
the fluctuating peaks from aa500 to 600, and the increasingly
disordered C-termini beginning at aa1100 and continuing
to the end of the proteins (Figure 4, shaded area 3). The
N-termini of zDBC1 and LST-3 have two gapped regions
(pink lines) that are located immediately before and after
the S1-Like domain. zCCAR1 contains two other gapped
segments similar to zDBC1, one near the center of the
protein that corresponds to the conserved Nudix domain
and another on the C-terminus that does not correspond
to a well-defined functional region. When compared to
either zCCAR1 or LST-3, zDBC1 contains four additional
gapped regions, thus indicating a difference of four insertions
or deletions throughout evolution. The locations of these
insertions and deletions are roughly in line with the gapped
segments in the sequence alignment provided in Figures S4
and S5.
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Figure 3: Phylogenetic analysis of DBC1 and CCAR1 homologs. A phylogenetic tree was built for all 93 protein sequences in 65 species as
listed in Table S1 using Mega5 software. All DBC1 proteins are on the left, while all CCAR1 proteins are on the right. The nematode LST-3
proteins, although closely related to CCAR1, are categorized into a subgroup of CCAR1. The colored shadows cover several regions that are
extensively discussed in the paper.

3.3. DBC1 Is More Conserved than CCAR1. The conservation of the genomic neighborhood (CGN) of DBC1 and
CCAR1 was calculated for mammals, birds, insects, reptile,
amphibians, and fish (Figure 5). The DBC1 gene is not present
in birds, insects, or amphibians, but in the species where
DBC1 gene is present, the CGN score of the DBC1 gene for
that species is higher than that of CCAR1. This is another
indication that the genomic region surrounding the CCAR1
gene is less conserved than the DBC1 gene.
Two synteny plots comparing the human and mouse
genes for DBC1 and CCAR1 are illustrated in Figure 6. In
these plots, more conserved genes can be found in the neighboring region of DBC1 as compared to CCAR1, also indicating that DBC1 is more conserved than CCAR1.
3.4. CCAR1 Appeared before DBC1 in Evolution. To further
examine the variability of insertions and deletions in DBC1
and CCAR1, the amino acid substitution rate of each conserved domain across various groups of species was analyzed
(Figure 7). The overall mutation rate for CCAR1 is approximately 20% from amphibian to human, while DBC1 has a

relatively high substitution rate of about 50% from insect to
mammal and 30% from Therapsida to primate. Even after
DBC1 becomes more conserved after Therapsida, the substitution rate of various domains in DBC1 is still approximately
10% higher than that of the corresponding CCAR1 domains.
Also, the mutation rate of each domain for DBC1 in fish is
similar to that of insects for CCAR1, indicating a similar trend
during the beginning of the evolutionary process between
both proteins, with CCAR1 evolving first.
Examination of each domain individually reveals that
the evolutionary process has varied between both proteins.
Interestingly, the fish DBC1 protein contains a SAP domain
that then disappears from amphibian and onward. The
remaining S1-Like, NLS, LZ, Nudix, and CC2 domains continue to have high mutation rates from fish to amphibian,
while the EF-Hand domain remains relatively conserved.
Variation continues to be observed between all domains until
a gradual steadying of mutation rates occurs in Therapsida
and continues until human.
The mutation rate of each domain in CCAR1 exhibits a
different trend. The mutation rate of the S1-Like, LZ, EFHand, SAP, NLS, and CC2 domains in CCAR1 varies from

1.0
0.8
0.6
0.4
0.2
0.0

1

0.5

zDBC1

200

400

600

800

1000

1.0
0.8
0.6
0.4
0.2
0.0

1200

1400

0.4
0.3
0.2

Turtle

Zebrafish

Lice

Frog

Honeybee

0.0
Pigeon

1400

Zebra finch

1.0
0.8
0.6
0.4
0.2
0.0

1200

Rat

1000

Turkey

800

Mouse

600

Horse

400

Bovine

200

Gorilla

0

0.1

Gibbon

zCCAR1

Chimpanzee

Disorder score

0.7

3

2

0.6

0

Disorder score

7

CGN

Disorder score

BioMed Research International

Species
LST-3
0

200

400

600
800
Residue index

1000

1200

1400

FIT

Figure 4: Gapped disorder prediction for zDBC1, zCCAR1, and
LST-3. The disorder prediction was analyzed by PONDR-FIT for
zebrafish DBC1 (zDBC1, UniProt ID: E7FGT1), zebrafish CCAR1
(zCCAR1, UniProt ID: F1QV66), and C. elegans LST-3 (UniProt
ID: G5EFJ2). Residues with a score higher than 0.5 on the 𝑦axis are disordered, while residues with score lower than 0.5 are
structured. The 𝑥-axis represents the amino acid number. The black
line represents the disorder prediction, while the pink horizontal
lines represent gapped segments. The shaded regions represent
similar patterns seen between all three proteins.

insects to fish, while the mutation rate between all domains
decreases from fish to amphibian. Limited changes occur
from amphibians to mammals in all domains except for the
NLS and CC1 domains, where the mutation rate decreases
more dramatically. This is followed by a further increase in
mutation rates in all domains from mammals to Therapsida,
with an eventual leveling off of the mutation rates in humans.
This data further supports CCAR1 appearing first in evolution, not only by appearing in insects before DBC1, but also
by becoming conserved much earlier in evolution.
3.5. DBC1 and CCAR1 Exhibit Similar Domain Flexibility. To
determine if the mutation rate of each domain has affected
protein structure and flexibility in the evolutionary process,
the average disorder score of each domain across different
species was compiled (Figure 8). The overall disorder scores
between the various domains of DBC1 and CCAR1 are very
similar. The NLS and CC2 domains are disordered in both
proteins, while the Nudix, S1-Like, EF-Hand, and LZ are
ordered domains. Also, the SAP domain in DBC1 that is only
present in fish is highly disordered, corresponding with the
intrinsic disorder of the SAP domain throughout CCAR1 evolution. Even though this overall similarity in structure exists,
differences can be seen in the trend of intrinsic disorder

CCAR1
DBC1

Figure 5: CGN score between human and other species for both
CCAR1 (black) and DBC1 (gray). A high CGN score of >0.5 indicates
that more than half of the gene neighbors are conserved within 2 Mb
and shows conservation of the local chromosomal environment,
while a score of <0.5 indicates that less than half of the neighboring
genes are conserved.

across evolution between each domain in DBC1 and CCAR1.
The S1-Like, Nudix, LZ, and EF-Hand domains in CCAR1
tend to become less structured throughout evolution, while
in DBC1 the same domains become more structured.
During the evolutionary process, it appears that some
domains underwent a drastic change in structural flexibility
that is measured by predicted disorder score. In DBC1, the S1Like and LZ domains decreased in structural flexibility from
fish to amphibian, whereas the opposite trend is observed
in CCAR1. The NLS and CC2 domains of DBC1 tend to
drastically change in structural flexibility where a vibration
pattern can be observed, before eventual leveling off into
a disordered structure in primates, and carrying over into
humans. In CCAR1, structural flexibility has increased in the
SAP domain from fish to amphibian, The NLS domain had
a sudden decrease in structural flexibility from mammals to
Therapsida, before increasing from primate to human.

4. Discussion
DBC1 and CCAR1 are emerging as important regulators in
a number of cellular pathways. DBC1 and CCAR1 share a
similar domain structure, indicating they may have similar
biological functions. The similar domain structure shared
between the two multidomain proteins may also indicate
origination from a common ancestor [91]. Therefore, it is
important to investigate the process by which the functional
domains of these two proteins have evolved. We predict here
for the first time that DBC1 and CCAR1 are comprised of
mostly intrinsically disordered regions, and that several of
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Figure 7: The amino acid substitution rates of specific domains among various groups of species for DBC1 (a) and CCAR1 (b). Based on the
sequences in Table S1, human is in one group, all other primates excluding human are in the second group, all other Therapsida excluding
primates are in the third group, all other mammals compose the fourth group, amphibians are in the fifth group, fish are in the sixth group,
and insects are in the seventh group. Eight domains were analyzed including the S1-Like, NLS, LZ, SAP, CC1, EF-Hand, and CC2 domains.

the functional domains in these two proteins are intrinsically
disordered. These findings provide support for the role
of these two proteins in many molecular interactions, as
intrinsically disordered regions are frequent sites for proteinprotein interactions [65]. In our prediction, the extended Nterminus of CCAR1 is much more flexible than that of DBC1,
as denoted by a higher disorder score, which may indicate a
unique functional role for this region. Corresponding to this,
CCAR1 has recently been shown to have distinct functions
apart from DBC1, such as binding directly to the LZ domain

of DBC1 and synergistically regulating the function of DBC1
[14]. This regulatory ability would require a unique region
capable of binding directly to DBC1, which our analysis
suggests may be on the N-terminal domain.
It is often found that two protein paralogs develop
throughout evolution from one common ancestor [92]. Supporting this notion, our analysis of DBC1 and CCAR1 from
multiple species has established evidence that both proteins
have evolved from one common nematode ancestor, LST-3.
We have shown that CCAR1 first appears in insects, while
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DBC1 first appears much later in fish. Further supporting this
claim is the fact that the DBC1 protein in fish is the only
species in which DBC1 contains a SAP domain, a domain
typically only found in CCAR1 proteins.
The SAP domain is a DNA/RNA binding domain with
about 40 amino acids. The core structure of this domain is
a two- or three-helix bundle. There are currently two X-ray
structures of SAP domains in the PDB; however, in these
two X-ray structures, the SAP domains are in complexes
with other proteins and RNA. Therefore, these two X-ray
structures of SAP domains cannot be used to assess the actual
structural flexibility of the SAP domain by itself. There are
also several other NMR structures for SAP domains in the
PDB database. From these structures, it is clear that the SAP
domain has huge structural flexibility. The RMSD values of
structural alignment between these structures from different
NMR experiments are very large. Therefore, results from
NMR experiments provide evidence that the SAP domain
is flexible. In addition, the length of the SAP domain is less
than 40 amino acids, indicating that the SAP domain may
not have enough hydrophobic interaction by itself. Further,
in our prediction, it is clear that SAP domain is likely to be in
a “dip” indicating a structure-prone tendency; however, this
“dip” is flanked by two long disordered regions. Therefore, the
possible 3D structural picture of the SAP domain is that this
domain forms a small and flexible hydrophobic core and sits
in the middle of a long disordered region. The SAP domain
of LST-3 was likely passed on to the fish DBC1 protein in
the early evolutionary history of DBC1. Other species may
not have required this particular domain in DBC1 and hence
continued to evolve without it. All of these findings combined
suggest that LST-3 is the common ancestor and ortholog, to
both DBC1 and CCAR1.
A gapped disorder plot shows that zDBC1 contains four
additional gapped regions when compared to zCCAR1 and

LST-3, indicating that a difference of four insertions/deletions
and/or substitutions allowed for the first evolutionary appearance of DBC1 in zebrafish. As mutation rate is linked to
evolution, understanding the mutation rates of these proteins
can help to decipher their evolutionary history. We see that
CCAR1 emerges earlier in evolution in insects and that it
becomes relatively conserved by the amphibian period with
the exception of the CC1 and the CC2 regions, which were
still undergoing evolution. DBC1, on the other hand, took
much longer to become relatively conserved, and still has
not yet reached the low mutation rate of CCAR1, indicating
the possibility of acquiring new functional roles in the future
evolutionary period. DBC1 becomes relatively conserved
in Therapsida. Taking into consideration that Therapsida
appeared about 300 million years later than amphibians, this
provides evidence that DBC1 arose much later in evolution
than CCAR1, further supporting the notion that a CCAR1
homolog gave rise to DBC1 over time.
Domain-level analysis provides yet more information on
the correlation between protein flexibility and evolution. The
disorder scores for the NLS and CC2 domains in DBC1 have
undergone drastic changes in the evolutionary process. This
may indicate the sudden acquisition of a hydrophobic core,
and thus an increased protein-binding ability. However, since
this new function may not be essential for the species, the
acquired hydrophobic binding sites may disappear in the
evolutionary process.
The LZ domain of DBC1 has been implicated in a variety
of regulatory processes. The LZ domain is a heptad repeat
of leucine residues, which represents the hydrophobic core
of a coiled-coil formed by two different chains. The basic
regions next to the LZ domain along the coiled-coil can
interact with the major groove of DNA to regulate the process
of gene expression. A substitution in heptad repeats from
hydrophobic to less-hydrophobic or hydrophilic and charged
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residues will lessen the hydrophobic interaction and distort
the structure of the coiled-coil and thereby prevent DNA
binding ability. Therefore, in order to keep the function of
the LZ domain, all of the mutations on this domain should
be hydrophobic-dominant and thus be more structure-prone
with a lower disorder score. In DBC1, the LZ domain tends to
become more structure-prone. Conversely, the LZ in CCAR1
loses structure slightly from insect to fish. It is interesting
to see this deviation since DBC1 first appears in fish. The
presence of DBC1 in fish may have resulted in a decreased
requirement for the LZ domain in CCAR1, ultimately affecting the current functional role of the LZ in modern DBC1
and CCAR1. This same concept is also applicable to all of the
structured domains as well.
Overall, our data presents new findings on the structure
and evolution of DBC1 and CCAR1. Our findings support
the function of both proteins in many protein-protein interactions due to the high occurrence of disordered residues.
We have found an unstructured region on the N-terminus of
CCAR1 that may be responsible for unique protein interactions independent of DBC1. Similarly, we have determined
that the LZ of DBC1 may be involved in unique interactions, as the LZ of CCAR1 has become unstructured and
possibly nonfunctional throughout evolution. We see that
CCAR1 appeared much earlier in the process of evolution
as compared to DBC1, and that the nematode LST-3 protein
may be the common ancestor of DBC1 and CCAR1. As the
nematode C. elegans is a model organism frequently used in
experimental biology; this work may help to broaden DBC1
and CCAR1 studies by demonstrating the important role that
nematodes have had in the evolution of these two proteins.
Specifically, the nematode LST-3 protein may have undergone
multiple insertions and deletions to give rise to modern-day
CCAR1 and DBC1.
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A. K. Dunker, “Intrinsic disorder in cell-signaling and cancerassociated proteins,” Journal of Molecular Biology, vol. 323, no.
3, pp. 573–584, 2002.
[39] A. K. Dunker, M. S. Cortese, P. Romero, L. M. Iakoucheva, and
V. N. Uversky, “Flexible nets: the roles of intrinsic disorder in
protein interaction networks,” FEBS Journal, vol. 272, no. 20, pp.
5129–5148, 2005.
[40] V. N. Uversky, C. J. Oldfield, and A. K. Dunker, “Showing your
ID: intrinsic disorder as an ID for recognition, regulation and
cell signaling,” Journal of Molecular Recognition, vol. 18, no. 5,
pp. 343–384, 2005.
[41] A. M. Szalkowski and M. Anisimova, “Markov models of amino
acid substitution to study proteins with intrinsically disordered
regions,” PLoS ONE, vol. 6, no. 5, Article ID e20488, 2011.
[42] B. Xue, C. J. Brown, A. K. Dunker, and V. N. Uversky, “Intrinsically disordered regions of p53 family are highly diversified in
evolution,” Biochimica et Biophysica Acta, vol. 1834, no. 4, pp.
725–738, 2013.
[43] S. F. Altschul, W. Gish, W. Miller, E. W. Myers, and D. J. Lipman,
“Basic local alignment search tool,” Journal of Molecular Biology,
vol. 215, no. 3, pp. 403–410, 1990.
[44] C. Camacho, G. Coulouris, V. Avagyan et al., “BLAST+: architecture and applications,” BMC Bioinformatics, vol. 10, article
421, 2009.
[45] M. Magrane and U. P. Consortium, “UniProt Knowledgebase:
a hub of integrated protein data,” Database: The Journal of
Biological Databases and Curation, vol. 2011, Article ID bar009,
2011.
[46] B. Xue, R. L. Dunbrack, R. W. Williams, A. K. Dunker, and
V. N. Uversky, “PONDR-FIT: a meta-predictor of intrinsically
disordered amino acids,” Biochimica et Biophysica Acta: Proteins
and Proteomics, vol. 1804, no. 4, pp. 996–1010, 2010.
[47] P. Romero, Z. Obradovic, X. Li, C. J. Brown, and A. K. Dunker,
“Sequence complexity of disordered protein,” Proteins, vol. 42,
no. 1, pp. 38–48, 2001.
[48] A. Schlessinger, M. Punta, G. Yachdav, L. Kajan, and B. Rost,
“Improved disorder prediction by combination of orthogonal
approaches,” PLoS ONE, vol. 4, no. 2, Article ID e4433, 2009.

12
[49] T. Ishida and K. Kinoshita, “Prediction of disordered regions in
proteins based on the meta approach,” Bioinformatics, vol. 24,
no. 11, pp. 1344–1348, 2008.
[50] X. Deng, J. Eickholt, and J. Cheng, “PreDisorder: ab initio
sequence-based prediction of protein disordered regions,” BMC
Bioinformatics, vol. 10, article 436, 2009.
[51] B. Xue, C. J. Oldfield, A. K. Dunker, and V. N. Uversky, “CDF
it all: consensus prediction of intrinsically disordered proteins
based on various cumulative distribution functions,” FEBS
Letters, vol. 583, no. 9, pp. 1469–1474, 2009.
[52] M. J. Mizianty, W. Stach, K. Chen, K. D. Kedarisetti, F. M.
Disfani, and L. Kurgan, “Improved sequence-based prediction
of disordered regions with multilayer fusion of multiple information sources,” Bioinformatics, vol. 26, no. 18, pp. i489–i496,
2010.
[53] L. P. Kozlowski and J. M. Bujnicki, “MetaDisorder: a metaserver for the prediction of intrinsic disorder in proteins,” BMC
Bioinformatics, vol. 13, article 111, 2012.
[54] S. Vucetic, C. J. Brown, A. K. Dunker, and Z. Obradovic,
“Flavors of protein disorder,” Proteins: Structure, Function and
Genetics, vol. 52, no. 4, pp. 573–584, 2003.
[55] K. Peng, P. Radivojac, S. Vucetic, A. K. Dunker, and Z.
Obradovic, “Length-dependent prediction of protein in intrinsic disorder,” BMC Bioinformatics, vol. 7, article 208, 2006.
[56] Z. Obradovic, K. Peng, S. Vucetic, P. Radivojac, C. J. Brown,
and A. K. Dunker, “Predicting intrinsic disorder from amino
acid sequence,” Proteins: Structure, Function and Genetics, vol.
53, supplement 6, pp. 566–572, 2003.
[57] K. Peng, S. Vucetic, P. Radivojac, C. J. Brown, A. K. Dunker, and
Z. Obradovic, “Optimizing long intrinsic disorder predictors
with protein evolutionary information,” Journal of Bioinformatics and Computational Biology, vol. 3, no. 1, pp. 35–60, 2005.
[58] J. Prilusky, C. E. Felder, T. Zeev-Ben-Mordehai et al., “FoldIndex: a simple tool to predict whether a given protein sequence is
intrinsically unfolded,” Bioinformatics, vol. 21, no. 16, pp. 3435–
3438, 2005.
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